Respiratory infections are common and sometimes very severe. An insufficient dosage of the antibiotic could lead to a treatment failure A correct plasmatic antibiotic concentration is not a guarantee of a clinical success as it could not be a reflect of pulmonary concentration. The aim of this study is to determinate the predictive factors of pulmonary penetration of antibiotics in patients with a beta lactamines failure and who undergoes a flexible bronchoscopy.
To check if pulmonary concentrations of antibiotic are enough we will measure antibiotic concentration in the broncho-alveolar lavage (BAL). This technique which is clinically relevant and reliable could determinate the pulmonary diffusion level for antibiotics by calculating the ratio between plasmatic and intra-alveolar antibiotic concentration. This ratio will be correlated with potential limitation factors of pulmonary diffusion as respiratory diseases (COPD, cystic fibrosis, fibrosis…), sepsis, hypoalbuminemia. We have chosen to study the beta lactamin antibiotics because they are the most frequently used in pneumonia. Moreover, the beta lactamins pulmonary diffusion is likely to be the lowest. Finally, for patients with a known pathogen, we will divide this pulmonary concentration with minimal inhibitory concentration (MIC). Indeed, in severe pneumonia, to be sure of bactericidal activity, a pulmonary concentration of beta lactamines should be always higher than 4 to 5 times MIC.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Enrollment
101
included patients will have a broncho-alveolar lavage (BAL) to measure intra-alveolar antibiotic concentration, and a blood test to measure plasmatic concentration
included patients will have a broncho-alveolar lavage (BAL) to measure intra-alveolar antibiotic concentration, and a blood test to measure plasmatic concentration
included patients will have a broncho-alveolar lavage (BAL) to measure intra-alveolar antibiotic concentration, and a blood test to measure plasmatic
CHU Amiens
Amiens, France
pulmonary diffusion level for beta lactamins
pulmonary diffusion level for beta lactamins is determined by ratio between bronchoalveolar concentration and plasmatic concentration of tested antibiotics
Time frame: on the day of the bronco-alveolar lavage
measure of apyrexia duration in days
measure of apyrexia duration in days
Time frame: from day of inclusion to 15 days after inclusion
duration in days for regression of the biological inflammatory syndrome
duration in days for regression of the biological inflammatory syndrome (CRP concentration in mg/l divided by 2)
Time frame: from day of inclusion to 15 days after inclusion
measure of length of hospitalisation
measure of length of hospitalisation in days
Time frame: from day of inclusion to 15 days after inclusion
Number of deaths at 28-day
28-day mortality will be measured
Time frame: 28 days after inclusion
virus presence in BAL
virus presence will be detected in bronchoalveolar lavage (BAL)
Time frame: day of bronchoalveolar lavage (BAL)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.